No Photo Available

Last Update

2015-09-24T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong ReGen Biologics?

ReGen Biologics

HQ Phone: (301) 827-6500

Email: r***@***.gov

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Food and Drug Administration

5630 Fishers Lane Rm. 1061

Rockville, Maryland 20852

United States

Company Description

China's Food and Drug Administration (SFDA) is now offering a reward of about 50,000 US dollars for relevant information on counterfeit drug production. The bounty aims to "encourage the public to report illegal activities so as to determine, control and ... more

Find other employees at this company (9,522)

Background Information

Employment History

Ivy Sports Medicine LLC

MassDevice

Audit Committee

OrthoSpineNews.com

SAFE HARBOR

Director of Clinical Affairs

Howmedica Osteonics Corp

Affiliations

Board Member
Orthopedic Products Company

Adds New Board Member
HealthpointCapital LLC

Adds New Board Member
Proteus Inc

Education

B.A.

biological science

Columbia College

Ph.D.

Web References (200 Total References)


ReGen Biologics Inc. Archives – MassDevice

www.massdevice.com [cached]

ReGen Biologics appeals loss to FDA

...
ReGen Biologics appeals loss to FDA
ReGen Biologics' long battle against the FDA entered a new phase this year, with the medical device company's appeal in a lawsuit it filed against the watchdog agency, its top regulator and the secretary of the U.S. Health & Human Services Dept. over the FDA's decision to rescind the clearance granted to ReGen's Menaflex knee implant.
...
FDA, ReGen Biologics
ReGen Biologics Inc. (OTC:RGBO) terminated its common stock registration in connection with its bankruptcy proceedings connected to the FDA's rescission of 510(k) clearance for the company's Menaflex knee implant.
Earlier this month ReGen sued the FDA, it's top regulator and the secretary of the U.S. Dept. of Health & Human Services, accusing them of overstepping their bounds in rescinding the clearance.
Filed Under: Business/Financial News, Legal News, News WellTagged With: ReGen Biologics Inc.
ReGen Biologics sues FDA over 510(k) rescission
June 1, 2011 By MassDevice staffLeave a Comment
ReGen Biologics, FDA
...
FDA, ReGen Biologics
ReGen Biologics Inc. (PINK:RGBO) filed for Chapter 11 bankruptcy protection with the U.S. Bankruptcy Court for the District of Delaware.
...
FDA, ReGen Biologics
ReGen Biologics Inc. (OTC:RGBO) is weighing options for the Menaflex knee implant the FDA forced off the market last week.
The agency rescinded its 2008 510(k) clearance for the Hackensack, N.J.-based company's embattled bio-absorbable knee implant last October. Last month ReGen rebuffed an offer from the FDA for a final hearing on the decision.
Filed Under: Food & Drug Administration (FDA), Implants, News WellTagged With: Knees, ReGen Biologics Inc.
ReGen Biologics: We're too broke to file our annual report
March 31, 2011 By MassDevice staffLeave a Comment
FDA, ReGen Biologics


ReGen Biologics terminates ...

www.medcitynews.com [cached]

ReGen Biologics terminates stock after suing FDA ReGen Biologics terminates stock after suing FDA

...
ReGen Biologics terminates stock after suing FDA
ReGen Biologics Inc. (OTC:RGBO) terminated its common stock registration in connection with its bankruptcy proceedings connected to the FDA's rescission of 510(k) clearance for the company's Menaflex knee implant.
Earlier this month ReGen sued the FDA, its top regulator, and the secretary of the U.S. Department of Health & Human Services, accusing them of overstepping their bounds in rescinding the clearance.
...
That decision came the same week that the FDAreleased a report saying ReGen failed to produce adequate evidence that device was safe before it was cleared to hit the market.
...
ReGen Biologics terminates stock after suing FDA


ReGen Biologics terminates ...

www.medcitynews.com [cached]

ReGen Biologics terminates stock after suing FDA ReGen Biologics terminates stock after suing FDA

...
ReGen Biologics terminates stock after suing FDA
ReGen Biologics Inc. (OTC:RGBO) terminated its common stock registration in connection with its bankruptcy proceedings connected to the FDA's rescission of 510(k) clearance for the company's Menaflex knee implant.
Earlier this month ReGen sued the FDA, its top regulator, and the secretary of the U.S. Department of Health & Human Services, accusing them of overstepping their bounds in rescinding the clearance.
...
That decision came the same week that the FDAreleased a report saying ReGen failed to produce adequate evidence that device was safe before it was cleared to hit the market.
...
ReGen Biologics terminates stock after suing FDA


ReGen Biologics terminates ...

www.medcitynews.com [cached]

ReGen Biologics terminates stock after suing FDA ReGen Biologics terminates stock after suing FDA

...
ReGen Biologics terminates stock after suing FDA
ReGen Biologics Inc. (OTC:RGBO) terminated its common stock registration in connection with its bankruptcy proceedings connected to the FDA's rescission of 510(k) clearance for the company's Menaflex knee implant.
Earlier this month ReGen sued the FDA, its top regulator, and the secretary of the U.S. Department of Health & Human Services, accusing them of overstepping their bounds in rescinding the clearance.
...
That decision came the same week that the FDAreleased a report saying ReGen failed to produce adequate evidence that device was safe before it was cleared to hit the market.
...
ReGen Biologics terminates stock after suing FDA


ReGen Biologics terminates ...

www.medcitynews.com [cached]

ReGen Biologics terminates stock after suing FDA ReGen Biologics terminates stock after suing FDA

...
ReGen Biologics terminates stock after suing FDA
ReGen Biologics Inc. (OTC:RGBO) terminated its common stock registration in connection with its bankruptcy proceedings connected to the FDA's rescission of 510(k) clearance for the company's Menaflex knee implant.
Earlier this month ReGen sued the FDA, its top regulator, and the secretary of the U.S. Department of Health & Human Services, accusing them of overstepping their bounds in rescinding the clearance.
...
That decision came the same week that the FDAreleased a report saying ReGen failed to produce adequate evidence that device was safe before it was cleared to hit the market.
...
ReGen Biologics terminates stock after suing FDA

Similar Profiles

Other People with this Name

Other people with the name Biologics

Ultra Bio-Logics
Ultra Bio-Logics Inc

Dir Biologics
Development Ctr for Biotechnology

MediVet Biologics
MediVet America LLC

ReGen Biologics
Vascular Dynamics Inc

Labrys Biologics
ReSurge International

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory